Dianthus Therapeutics (DNTH) EBITDA (2017 - 2025)
Dianthus Therapeutics (DNTH) posted EBITDA of -$40.26 million for Q3 2025, compared with -$29.88 million a year earlier.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) EBITDA (2017 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, EBITDA at Dianthus Therapeutics was -$140.2 million; for FY2024, it came in at -$101.77 million.
- In prior years, Dianthus Therapeutics' EBITDA was -$48.11 million in FY2023, -$27.78 million in FY2022, -$72.67 million in FY2021 and -$76.7 million in FY2020.
- The Q3 2025 figure stands as the lowest quarterly EBITDA in data going back to Q3 2017.
- According to Business Quant data, EBITDA for the three prior quarters was -$34.9 million (Q2 2025), -$33.15 million (Q1 2025) and -$31.89 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Dianthus Therapeutics | 3.76 Bn | 3.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -40.26 Mn |
| Jun 30, 2025 | -34.90 Mn |
| Mar 31, 2025 | -33.15 Mn |
| Dec 31, 2024 | -31.89 Mn |
| Sep 30, 2024 | -29.88 Mn |
| Jun 30, 2024 | -22.18 Mn |
| Mar 31, 2024 | -17.82 Mn |
| Dec 31, 2023 | -12.94 Mn |
| Sep 30, 2023 | -15.74 Mn |
| Jun 30, 2023 | -11.78 Mn |
| Mar 31, 2023 | -7.26 Mn |
| Dec 31, 2022 | -10.23 Mn |
| Sep 30, 2022 | -7.78 Mn |
| Jun 30, 2022 | -17.61 Mn |
| Mar 31, 2022 | -23.32 Mn |
| Dec 31, 2021 | -19.61 Mn |
| Sep 30, 2021 | -17.71 Mn |
| Jun 30, 2021 | -17.13 Mn |
| Mar 31, 2021 | -18.22 Mn |
| Dec 31, 2020 | -18.55 Mn |
API Access
Dianthus Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();